PMLiVE9h
AstraZeneca’s Imfinzi recommended by CHMP to treat small cell lung cancer
The Committee for Medicinal Products for Human Use (CHMP) has recommended that the immunotherapy be approved to treat adults ...
PMLiVE9h
J&J’s subcutaneous Rybrevant receives positive CHMP opinion for advanced lung cancer
The Committee for Medicinal Products for Human Use (CHMP) has recommended that the subcutaneous (SC) formulation be approved ...
PMLiVE9h
MHRA approves CSL’s Andembry to treat angioedema attacks in HAE patients
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved CSL’s Andembry (garadacimab) to prevent ...
PMLiVE10h
Why events should be part of your 2025 growth strategy
Over eighty per cent of businesses rank in-person events as their most impactful marketing channel. In fact, 48 per cent of ...
PMLiVE11h
Optimising business partnerships for success and sustainability
Challenging times can put a strain on any relationship, making it harder to keep everything working in harmony. The ...